当前位置:首页 - 行情中心 - 安科生物(300009) - 财务分析

安科生物

(300009)

  

流通市值:103.23亿  总市值:141.33亿
流通股本:12.22亿   总股本:16.73亿

安科生物(300009)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润7.16亿元,每股收益0.42元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益429993.77万元,未分配利润162000.83万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产513534.99万元,负债83541.22万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入2,536,042,781.681,921,280,101.121,298,815,000.98656,092,096.17
营业总成本1,780,935,163.991,268,341,322.03842,210,918.23412,632,143.81
营业利润806,396,813.46699,364,367492,996,844.14257,600,663.55
利润总额803,016,702.92698,275,336.46492,018,081.44257,619,264.62
净利润715,837,906.16599,915,131.57423,770,648.17221,942,342.95
其他综合收益----
综合收益总额715,837,906.16599,915,131.57423,770,648.17221,942,342.95
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计2,275,095,785.012,240,715,100.012,161,578,860.882,512,247,494.21
非流动资产合计2,860,254,070.712,750,263,372.72,683,092,986.592,614,458,147.18
资产总计5,135,349,855.724,990,978,472.714,844,671,847.475,126,705,641.39
流动负债合计667,585,431.63699,754,762.31739,846,515.21793,045,617.92
非流动负债合计167,826,723.08158,813,455.35154,519,846.06167,764,792.3
负债合计835,412,154.71858,568,217.66894,366,361.27960,810,410.22
归属于母公司股东权益合计4,124,312,564.423,937,686,124.913,750,250,207.423,966,402,036.48
股东权益合计4,299,937,701.014,132,410,255.053,950,305,486.24,165,895,231.17
负债和股东权益合计5,135,349,855.724,990,978,472.714,844,671,847.475,126,705,641.39
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计2,505,216,350.951,875,989,512.271,235,075,413.48623,525,658.51
经营活动现金流出小计1,819,844,403.861,455,085,023.091,029,267,158.07468,795,288.46
经营活动产生的现金流量净额685,371,947.09420,904,489.18205,808,255.41154,730,370.05
投资活动现金流入小计1,262,223,715.451,160,526,336.561,031,542,969.92905,331,713.15
投资活动现金流出小计1,432,471,328.521,044,603,561.67827,399,567.961,002,074,899.5
投资活动产生的现金流量净额-170,247,613.07115,922,774.89204,143,401.96-96,743,186.35
筹资活动现金流入小计5,000,0005,000,0005,000,000-
筹资活动现金流出小计480,379,750.73449,876,950.15432,138,5252,197,333.4
筹资活动产生的现金流量净额-475,379,750.73-444,876,950.15-427,138,525-2,197,333.4
汇率变动对现金及现金等价物的影响76,401.9447,093.95159,350.0913,564.21
现金及现金等价物净增加额39,820,985.2391,997,407.87-17,027,517.5455,803,414.51
期末现金及现金等价物余额298,604,934.97350,781,357.61241,756,432.2314,587,364.25
最新报告期:2025-02-11
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国金证券袁维0.480.590.712025-02-11
TOP↑